Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/connect-biopharma-uncouples-pfizer-scrapping-long-standing-eczema-pact
https://www.globenewswire.com/news-release/2024/04/16/2864093/0/en/Connect-Biopharma-Reports-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/03/19/2848567/0/en/Connect-Biopharma-to-Participate-in-H-C-Wainwright-2%E2%81%BF%E1%B5%88-Annual-Autoimmune-Inflammatory-Disease-Virtual-Conference.html
https://www.globenewswire.com//news-release/2024/02/12/2827878/0/en/Connect-Biopharma-Appoints-Industry-Veteran-James-Huang-to-Board-of-Directors.html
https://www.globenewswire.com//news-release/2024/02/12/2827878/0/en/Connect-Biopharma-Appoints-Industry-Veteran-James-Huang-to-Board-of-Directors.html
https://www.prnewswire.com/news-releases/rigel-announces-collaboration-with-connect-to-conduct-a-phase-2-trial-of-olutasidenib-in-glioma-302026029.html
https://www.globenewswire.com//news-release/2023/12/12/2794548/0/en/Connect-Biopharma-Announces-Positive-Rademikibart-Global-Phase-2b-Topline-Results-in-Adult-Patients-with-Moderate-to-Severe-Persistent-Asthma.html
https://www.fiercebiotech.com/biotech/connect-biopharma-plots-phase-3-regulatory-path-after-asthma-asset-hits-mid-stage-trial
https://www.globenewswire.com//news-release/2023/12/11/2794255/0/en/Connect-Biopharma-to-Announce-Top-Line-Data-from-the-Global-Phase-2b-Trial-of-Rademikibart-in-Patients-with-Moderate-to-Severe-Asthma-on-December-12-2023.html
https://www.globenewswire.com//news-release/2023/11/21/2783847/0/en/Connect-Biopharma-and-Simcere-Announce-Exclusive-Licensing-and-Collaboration-Agreement-in-Greater-China.html